Yanhui Li Selected Research

Yanhui Li Research Topics

Disease

26	Neoplasms (Cancer) 11/2021 - 04/2007
8	Inflammation (Inflammations) 01/2021 - 04/2013
4	Overweight 10/2022 - 12/2020
4	Obesity 10/2022 - 02/2021
3	Sepsis (Septicemia) 01/2021 - 01/2020
3	Fibrosis (Cirrhosis) 01/2020 - 01/2014
3	Myocardial Infarction 01/2016 - 07/2010
2	Pediatric Obesity 08/2022 - 01/2022
2	Carcinoma (Carcinomatosis) 04/2022 - 01/2019
2	Hypertension (High Blood Pressure) 03/2022 - 12/2021
2	Dyslipidemias (Dyslipidemia) 02/2022 - 12/2021
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 06/2014
2	Infections 01/2022 - 01/2016
2	Bacterial Infections (Bacterial Infection) 01/2022 - 12/2020
2	Neoplasm Metastasis (Metastasis) 11/2021 - 10/2021
2	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2017
2	Wounds and Injuries (Trauma) 01/2021 - 01/2021
2	Pain (Aches) 01/2021 - 01/2017
2	Ventricular Tachycardia 08/2020 - 06/2018
2	Parkinson Disease (Parkinson's Disease) 06/2019 - 01/2017
2	Weight Gain 05/2019 - 01/2019
2	Progeria (Hutchinson Gilford Syndrome) 01/2019 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 04/2013
2	Leukemia 06/2015 - 05/2013
2	Body Weight (Weight, Body) 03/2015 - 04/2007
1	Vision Disorders (Hemeralopia) 10/2022
1	Channelopathies 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Familial Sudden Death 01/2022
1	Ventricular Fibrillation 01/2022
1	Proximal Femoral Fractures 01/2022
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022
1	Hyperlipidemias (Hyperlipidemia) 12/2021
1	Gestational Weight Gain 06/2021
1	Insulin Resistance 02/2021

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2022 - 04/2007
5	CollagenIBA 01/2022 - 06/2014
4	Biological ProductsIBA 01/2021 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2015 - 04/2007
3	Environmental Pollutants (Pollutants, Environmental)IBA 10/2022 - 07/2014
3	ORALIT (ORS)IBA 01/2022 - 01/2021
3	CalciumIBA 01/2022 - 01/2016
3	Insulin (Novolin)FDA Link 02/2021 - 07/2010
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2021
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2022 - 01/2022
2	Fibronectins (Fibronectin)IBA 01/2022 - 01/2020
2	Biocompatible Materials (Biomaterials)IBA 01/2021 - 01/2019
2	Metal-Organic FrameworksIBA 01/2021 - 12/2019
2	carboxymethyl-chitosanIBA 01/2021 - 01/2021
2	Dinoprostone (PGE2)FDA Link 01/2021 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 07/2010
2	AcidsIBA 01/2020 - 01/2018
2	Glutathione (Reduced Glutathione)IBA 01/2020 - 12/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2019 - 12/2019
2	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 01/2017
2	Sucrose (Saccharose)IBA 01/2019 - 01/2017
2	Anesthetics (Anesthetic Agents)IBA 01/2019 - 01/2019
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 01/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2018 - 10/2009
2	PolyethyleneimineIBA 04/2018 - 06/2016
2	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 10/2009
2	C-Reactive ProteinIBA 01/2016 - 04/2013
2	HydrogelsIBA 10/2015 - 01/2013
2	Antineoplastic Agents (Antineoplastics)IBA 07/2014 - 05/2013
2	Hematoxylin (Haematoxylon)IBA 06/2014 - 07/2013
2	Eosine Yellowish-(YS) (Eosin)IBA 06/2014 - 07/2013
2	graphene oxideIBA 01/2014 - 01/2014
1	dimemorfan (AT 17)IBA 10/2022
1	Air Pollutants (Pollutants, Air)IBA 08/2022
1	SaltsIBA 04/2022
1	Particulate MatterIBA 03/2022
1	monobutyl phthalateIBA 02/2022
1	phthalic acid (phthalate)IBA 02/2022
1	LipidsIBA 02/2022
1	Endocrine DisruptorsIBA 01/2022
1	indium-bleomycinIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2022
1	phenyl-2-aminoethyl sulfide (PAES)IBA 01/2022
1	Flecainide (Tambocor)FDA LinkGeneric 01/2022
1	Dexmedetomidine FDA Link 01/2022
1	Gatifloxacin (Zymar)FDA Link 01/2022
1	Triglycerides (Triacylglycerol)IBA 12/2021
1	Tuberculin (PPD)IBA 11/2021
1	ELAV-Like Protein 1IBA 10/2021
1	Docosahexaenoic AcidsIBA 02/2021
1	Eicosapentaenoic AcidIBA 02/2021

Therapy/Procedure

16	Therapeutics 11/2021 - 10/2010
4	Drug Therapy (Chemotherapy) 05/2018 - 10/2010
3	Photochemotherapy (Photodynamic Therapy) 12/2019 - 05/2014
2	General Anesthesia 01/2022 - 01/2019
2	Precision Medicine 01/2020 - 11/2015
2	Photothermal Therapy 01/2020 - 11/2015
1	Immunotherapy 11/2021
1	Bed Rest (Bedrest) 06/2021